NEW YORK, June 25, 2019 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Allergan plc (“Allergan” or the “Company”) (NYSE: AGN) stock prior to June 25, 2019.
You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale ofAllergan to AbbVie Inc. (“AbbVie”) (NYSE: ABBV). Under the terms of the deal, Allergan Shareholders will receive 0.8660 AbbVie Shares and $120.30 in cash for each Allergan Share that they hold. To learn more about the action and your rights, go to:
or contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500. There is no cost or obligation to you.
The Allergan merger investigation concerns whether the Board of Allergan breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether AbbVie is underpaying for Allergan shares, thus unlawfully harming Allergan shareholders.
Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
© 2019 Canjex Publishing Ltd. All rights reserved.